Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination Androgen Receptor Inhibition and Docetaxel in Metastatic Castration-sensitive Prostate Cancer: The Next Step in First-line Treatment?
Adashek JJ, Reed JP, Tandon A, Freedland SJ, Posadas E, Bhowmick N, Chung LW, Freeman M, Figlin RA, Gong J. Adashek JJ, et al. Among authors: gong j. Clin Genitourin Cancer. 2020 Dec;18(6):425-428. doi: 10.1016/j.clgc.2020.05.003. Epub 2020 May 11. Clin Genitourin Cancer. 2020. PMID: 32631766 Free PMC article. Review.
COVID-19 and androgen-targeted therapy for prostate cancer patients.
Bhowmick NA, Oft J, Dorff T, Pal S, Agarwal N, Figlin RA, Posadas EM, Freedland SJ, Gong J. Bhowmick NA, et al. Among authors: gong j. Endocr Relat Cancer. 2020 Sep;27(9):R281-R292. doi: 10.1530/ERC-20-0165. Endocr Relat Cancer. 2020. PMID: 32508311 Free PMC article. Review.
Integrating PARP Inhibitors Into Advanced Prostate Cancer Therapeutics.
Gong J, Posadas E, Bhowmick N, Kim H, Daskivich T, Gupta A, Sandler H, Kamrava M, Zumsteg Z, Freedland S, Figlin R. Gong J, et al. Oncology (Williston Park). 2021 Mar 15;35(3):119-125. doi: 10.46883/ONC.2021.3503.0119. Oncology (Williston Park). 2021. PMID: 33818052 Review.
Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection.
LeVee A, Lin CY, Posadas E, Figlin R, Bhowmick NA, Di Vizio D, Ellis L, Rosser CJ, Freeman MR, Theodorescu D, Freedland SJ, Gong J. LeVee A, et al. Among authors: gong j. Onco Targets Ther. 2021 Sep 15;14:4819-4832. doi: 10.2147/OTT.S315170. eCollection 2021. Onco Targets Ther. 2021. PMID: 34552338 Free PMC article. Review.
8,297 results